1. Home
  2. JNJ

JNJ

Johnson & Johnson

as 03-28-2025 4:00pm EST

$
-
-
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Founded: 1886 Country:
United States
United States
Employees: N/A City: NEW BRUNSWICK
Market Cap: N/A IPO Year: 1944
Target Price: $170.75 AVG Volume (30 days): 8.7M
Analyst Decision: Buy Number of Analysts: 17
Dividend Yield:
3.03%
Dividend Payout Frequency: Quarterly
EPS: 5.79 EPS Growth: -57.81
52 Week Low/High: $140.68 - $169.99 Next Earning Date: 04-15-2025
Revenue: $88,821,000,000 Revenue Growth: 4.30%
Revenue Growth (this year): 2.12% Revenue Growth (next year): 4.11%

JNJ Daily Stock ML Predictions

Stock Insider Trading Activity of Johnson & Johnson (JNJ)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Decker Robert J JNJ VP Corporate Controller Feb 25 '25 Sell $165.88 6,999 $1,160,994.12 21,001
Schmid Timothy JNJ EVP, WW Chair, MedTech Feb 13 '25 Sell $156.15 403 $62,928.45 15,098
Wolk Joseph J JNJ Exec VP, CFO Feb 7 '25 Sell $153.89 13,015 $2,002,878.35 0

Share on Social Networks: